Overview
Intranasal administration is a method used to deliver medications and vaccines through the nasal passageway. This method of administration is becoming increasingly popular due to its ease of use and enhanced bioavailability, as it avoids first-pass metabolism that occurs with oral delivery. Intranasal administration has the potential to reduce the amount of drug needed, thus improving safety and efficacy of the medication. Furthermore, this administration route could be useful in improving the treatment of neurological and mental illnesses, as drugs can be directly delivered to the brain. In general, intranasal administration has the potential to reduce side effects, improve drug efficacy, and offer an alternative to oral delivery.
Research published in this journal
4 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The Novel Coronavirus 2019 (COVID-19): A Narrative Review
Pleomorphic Adenoma of The Nasal Septum
Development of Poly-ε-Caprolactone Based Nanoadjuvant for Effective Vaccination Against Tuberculosis
How this research is being cited
The 4 articles above have been cited 17 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2024 · International Journal of Surgery Case Reports
-
2024 · International Journal of Surgery Case Reports
-
2023 · Oxford Medical Case Reports
-
2023 · Indian Journal of Otolaryngology and Head & Neck Surgery
-
2023 · Oxford Medical Case Reports
-
2023 · Indian Journal of Otolaryngology and Head & Neck Surgery
-
2023 · Elsevier eBooks
-
A. Kubota et al. · 2021 · Ear, nose, & throat journal
A sample of recent works citing this journal's research on Intranasal Administration, linking to each citing work.